PL125785B1 - Process for preparing novel octahydro-2h-pyrrole /3,4-g/-quinolines - Google Patents

Process for preparing novel octahydro-2h-pyrrole /3,4-g/-quinolines Download PDF

Info

Publication number
PL125785B1
PL125785B1 PL1979216721A PL21672179A PL125785B1 PL 125785 B1 PL125785 B1 PL 125785B1 PL 1979216721 A PL1979216721 A PL 1979216721A PL 21672179 A PL21672179 A PL 21672179A PL 125785 B1 PL125785 B1 PL 125785B1
Authority
PL
Poland
Prior art keywords
group
quinolines
pyrrole
preparing novel
acid
Prior art date
Application number
PL1979216721A
Other languages
English (en)
Polish (pl)
Other versions
PL216721A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,642 external-priority patent/US4235909A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL216721A1 publication Critical patent/PL216721A1/xx
Publication of PL125785B1 publication Critical patent/PL125785B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1979216721A 1979-01-22 1979-06-29 Process for preparing novel octahydro-2h-pyrrole /3,4-g/-quinolines PL125785B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506279A 1979-01-22 1979-01-22
US06/031,642 US4235909A (en) 1979-04-19 1979-04-19 Octahydro-2H-pyrrolo[3,4-g]quinolines

Publications (2)

Publication Number Publication Date
PL216721A1 PL216721A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-06-16
PL125785B1 true PL125785B1 (en) 1983-06-30

Family

ID=26673871

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1979216721A PL125785B1 (en) 1979-01-22 1979-06-29 Process for preparing novel octahydro-2h-pyrrole /3,4-g/-quinolines

Country Status (25)

Country Link
EP (1) EP0013788B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS55100385A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR225012A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT365189B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU528035B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE877328A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1131227A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH641801A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD144668A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2965277D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK268979A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES482084A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI65248C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2446833A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2040917B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE48295B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL57665A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU81440A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ190834A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (2) PH15118A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL125785B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT69828A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO77442A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1113006A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA793244B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
EP0127708B1 (en) * 1983-06-03 1987-09-09 Eli Lilly And Company Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
AR067027A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.
TWI537274B (zh) * 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Also Published As

Publication number Publication date
PH16181A (en) 1983-07-25
CA1131227A (en) 1982-09-07
EP0013788B1 (en) 1983-04-27
GB2040917B (en) 1983-01-06
IE48295B1 (en) 1984-11-28
PT69828A (en) 1979-07-01
IL57665A0 (en) 1979-10-31
SU1113006A3 (ru) 1984-09-07
EP0013788A1 (en) 1980-08-06
FR2446833A1 (fr) 1980-08-14
FI792047A7 (fi) 1980-07-23
DD144668A5 (de) 1980-10-29
AU4844479A (en) 1980-07-31
AR225012A1 (es) 1982-02-15
JPS55100385A (en) 1980-07-31
PL216721A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-06-16
NZ190834A (en) 1984-07-06
FI65248B (fi) 1983-12-30
GB2040917A (en) 1980-09-03
CH643258A5 (fr) 1984-05-30
IE791210L (en) 1980-10-19
FR2446835A1 (fr) 1980-08-14
RO77442A (ro) 1982-10-26
JPS6233233B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-07-20
AU528035B2 (en) 1983-04-14
FI65248C (fi) 1984-04-10
LU81440A1 (fr) 1979-09-12
AT365189B (de) 1981-12-28
DE2965277D1 (en) 1983-06-01
DK268979A (da) 1980-07-23
CH641801A5 (fr) 1984-03-15
ATA452579A (de) 1981-05-15
IL57665A (en) 1982-11-30
FR2446835B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-04-23
PH15118A (en) 1982-08-10
ZA793244B (en) 1981-02-25
BE877328A (fr) 1979-12-28
ES482084A1 (es) 1980-08-01
FR2446833B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-03-05

Similar Documents

Publication Publication Date Title
FI79302C (fi) Foerfarande foer framstaellning av farmakologiskt aktiva trifenylimidazolyloxialkansyror och derivat daerav.
KR970705558A (ko) 항진균 활성을 갖는 신규 피리미돈 유도체(new pyrimidone derivatives with antifungal activity)
PL125785B1 (en) Process for preparing novel octahydro-2h-pyrrole /3,4-g/-quinolines
HRP20151439T1 (hr) Halogenirani derivati benzamida
YU46696B (sh) Postupak za dobijanje oksoftalazinil sirćetnih kiselina koje imaju benzotiazolne ili druge heterociklične bočne nizove
FI78298B (fi) Foerfarande foer framstaellning av penicillansyra-1,1-dioxid och dess derivat.
US4382940A (en) Ercoline derivatives and therapeutic compositions having CNS affecting activity
AU5453500A (en) Preparation of substituted piperidin-4-ones
GB1062714A (en) -ß-(4'-acyloxy-4'-piperidyl)-ketones
FI895325A0 (fi) Menetelmä terapeuttisesti tehokkaiden 4(5)-asemassa bisyklisellä ryhmällä substituoitujen imidatsolien valmistamiseksi
US6207828B1 (en) Process for making 2-(trihaloacetyl)-3-(substituted amino)-2-propenoates
JP2018536652A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY1107515T1 (el) Συνθεση ενδιαμεσων χρησιμων στην παρασκευη τρικυκλικων ενωσεων
AU753563B2 (en) Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives
GR70356B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS6018702B2 (ja) 光学的増白剤及びその製法
JPS57142966A (en) (1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
GB1105219A (en) New condensed heterocyclic compounds their production and composition containing same
IE922236A1 (en) Process for the preparation of the dextrorotatory isomer of a 2-aminonaphthyridine derivative
RU96104371A (ru) Фармакологически активные энантиомеры
US4211709A (en) Aminopyrrole derivatives
GB1456946A (en) 6-phenyl-4h-imidazo-1,2-a-1,4-benzodiazepines
US3641019A (en) Thiazolo-as-triazines
FI95248B (fi) Tiatsolietanolijohdannaisia, menetelmä niiden valmistamiseksi ja niiden välituotteet
MXPA00010964A (en) Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives